Anserine

Modest human trial data for uric acid reduction and anti-glycation. Generally safe as a dietary supplement but effects are mild.

A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.

Several small Japanese RCTs show modest uric-acid-lowering and anti-glycation effects. Often studied alongside carnosine.

• Mild uric acid reduction in clinical trials
• Antioxidant and anti-glycation properties
• Generally recognized as safe in food-derived doses

Human trials typically use 500–1000 mg/day of anserine/carnosine mixtures.

• GI discomfort at high doses
• Fish/poultry allergen risk

Generally well tolerated. Sourced from fish/poultry, so allergen risk applies.

Human trials are small and mostly from a single research group. Effect sizes are modest.

• Longevity30
• Recovery20